Clinical trials
Lymphoma, T-Cell trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2009 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Seagen Inc. | 2 |
| AHS Cancer Control Alberta | 1 |
| Acrotech Biopharma Inc. | 1 |
| BeiGene | 1 |
| CRISPR Therapeutics AG | 1 |
| City of Hope Medical Center | 1 |
| Corvus Pharmaceuticals, Inc. | 1 |
| Pfizer | 1 |
| Prelude Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 17 |
| Lymphoma | 9 |
| Lymphoma, Large-Cell, Anaplastic | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Lymphoma, T-Cell, Cutaneous | 5 |
| Lymphoma, T-Cell, Peripheral | 5 |
| Immunoblastic Lymphadenopathy | 4 |
| Hematologic Neoplasms | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Hematologic Diseases | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.